Letter from Jean-Christophe Pointeau China President, Pfizer Global Biopharma Business Group
Science
Oncology
Vaccines
Anti Infectives
Inflammation & Immunology
Rare Disease
Product
Annual Report
2023 was a year of several challenges, it was also a year of significant accomplishments.